Sarah Cannon and HCA Research Institute

Nashville, Tennessee 37221

2 studies enrolling now · 10 studies all time

What they study most

ATC, Advanced Cancer, Advanced Epithelioid Sarcoma, Advanced Soft-tissue Sarcoma, Advanced Solid Tumor, Advanced Solid Tumor Historically Known for High EphA2 Expression, CRC, Cancer, Cancer Metastatic, Covid19, EGFR, Epidermal Growth Factor

Studies at this site

• A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC — Recruiting now
• FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3 — Recruiting now
• A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies — Running, not enrolling
• A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment — Completed
• Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma — Stopped early
• A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors — Completed
• Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression — Running, not enrolling
• HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer — Running, not enrolling
• Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE — Completed
• Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) — Running, not enrolling